It seems to coincide that when fraudulent medical or nutritional dogma promoted by mainstream medicine or government nutritional institutions starts getting exposed in the alternative media, they both double down with the aid of mainstream media, especially if the result of that exposure is lowered sales of statin drugs and processed non-fat foods. This is what is happening with both statin drugs and saturated fat disinformation. But now the empire is striking back. Cleveland Clinic cardiologist Dr. Steven Nissen writes: "We are losing the battle for the hearts and minds of our patients to websites developed by people with little or no scientiﬁc expertise, who often peddle ‘natural’ or ‘drug-free’ remedies for elevated cholesterol levels. This 'Internet-driven cult' denies statins’ benefits and whips up fears of side effects, then profits from the resulting confusion by peddling snake oil. The diversion of patients away from evidence-based therapy by advocates of unproven dietary supplements must be vigorously opposed by physician-scientists. Similarly, the claims that cult diets can reverse heart disease have no scientific basis and represent a danger to public health." Dr. Nissen’s viewpoint was also covered in a MedPage Today article titled “CardioBrief: Statin Denialism Is 'A Deadly Internet-Driven Cult,'" where Dr. James Stein (University of Wisconsin) supported Dr. Nissen’s editorial with more vitriol than even Dr. Nissen expressed, stating: "There is a special place in hell for people who use fear tactics and misinformation to promote books and natural health aids, including crazy diets, at the expense of proven medical therapies, rather than as complimentary options under medical direction. I am not sure why Americans are so susceptible to these charlatans."
Aggressive lowering of low-density lipoprotein cholesterol (LDL-C) has been the cornerstone of preventative cardiology for decades. Statins are widely used as the go-to solution for the prevention of heart disease owing to their ability to slash LDL-C levels, a ‘surrogate marker’ of cardiovascular disease (CVD). Indeed, statins are one of the most widely prescribed class of drugs in the world. But this phenomenon begs two questions: is the enthusiasm for aggressive lowering of LDL-C justified; and is pharmacotherapy superior to lifestyle intervention? In summary, for many patients at high risk of CVD, one of the safest and most effective ways to reduce the risk of heart attack and stroke is to consume a high fat and low glycaemic load Mediterranean diet and engage in regular exercise. At the very least, exercise interventions are often similar to drug interventions in terms of their mortality benefits in the secondary prevention of coronary heart disease, and do not come with side effects.
A Penn State Medical School epidemiological study, reported by Science Daily, is urging physicians to not prescribe statin drugs for Parkinson’s disease symptoms. Evidently, due to earlier studies, cholesterol reducing drugs were considered preventative of Parkinson’s disease. Amazingly, this practice had been going on for some time, thanks to several questionable, and conflicting studies of statin use and Parkinson’s disease. The most recent study was conducted at the Penn State College of Medicine earlier this year (2017.) Their conclusion asserts that statin drugs should not be used as a Parkinson’s disease (PD) preventative. A previous study claimed patients who stopped taking statin drugs were more prone to Parkinson’s disease, thus statin drugs were helpful for preventing Parkinson’s. The Penn State study provided evidence that the opposite is true. Statin drug use can lead to Parkinson’s disease.
Shocking news! Two studies were recently published that endorse 2013 guidelines for a wider use of statin drugs. As reported in the Journal of the American Medical Association (JAMA), out of over 2400 people, 39% were statin eligible, compared with 14% by the old 2004 guidelines. In one fell swoop, the amount of people recommended for statin use was tripled! This is not surprising given the amount of revenue from statin drug sales. Who makes the guidelines? Doctors on Big Pharma payroll, that’s who.
Heart disease, as many of us know, is one of the leading causes of death in the US, killing about 610,000 people each year. Big Pharma—in the belief that cholesterol is the primary factor in heart disease—developed statin drugs that would lower cholesterol and reduce the risk of heart disease. The drugs, which have been accompanied by massive marketing campaigns, are huge moneymakers for the drug industry, to the tune of about $29 billion worth of sales in 2013. That’s the kind of outrageous money you make when you convince one in four Americans over the age of 45 to take statins. What the American Heart Association does not seem to understand is that cholesterol is vital to human health. We’ve noted in the past that cholesterol isn’t the ticking time bomb most people have been led to think—in fact, the real danger is that our cholesterol levels can get too low as we age! Even “bad” cholesterol is essential.
Cholesterol-lowering statin drugs may stimulate atherosclerosis and heart failure. Statins inhibit the synthesis of vitamin K2 in your body; vitamin K2 protects your arteries from calcification. Statins may also damage your heart by interfering with CoQ10 production, causing mitochondria damage, and interfering with selenium-containing proteins.
Another study has confirmed that statin drug use increases one's chance of developing diabetes. Statin drugs are the all-time leading prescription drugs sold in the U.S. and around the world, prescribed by doctors to lower people's cholesterol levels. It is estimated that one out of every 4 people in the United States over the age of 50 is currently taking statin drugs for cholesterol. This current study just published looked at 26,000 beneficiaries of Tricare, the military health system. They found that those taking statin drugs to control their cholesterol were 87 percent more likely to develop diabetes. The study was published in the Journal of General Internal Medicine. This is just the latest study to link statin drugs to diabetes, especially in women. Studies published in 2014 caused over 2000 lawsuits to be filed against Pfizer, the maker of the best-selling drug of all-time, Lipitor.
The cholesterol-lowering statin drug empire continues to crumble. On Sunday February 15, 2015, the Sunday Express in the UK published a headline story stating that Oxford professor Dr. Rory Collins, whose research had been used to support putting millions of patients on statin drugs, was reassessing the data behind those studies for possible drug side effects. According to the Express: "Although the original research looked at the effect of statins on the heart and considered cancer risks it did not examine other side effects." This announcement by Dr. Collins is stunning, to say the least, and points to a massive cover-up and scandal related to statin drugs.
Here is a fact that has been known for quite a long time, but it is still news to many people: People with higher cholesterol levels live longer than people with lower cholesterol levels. The reason why this fact is not well-known in the general public is because it would put a huge dent into a $100 BILLION drug market for statin drugs - drugs that lower your cholesterol. With approximately one out of every 4 Americans over the age of 50 currently prescribed a statin drug, a drug with very serious side effects, this is certainly one issue you should investigate yourself.
Before its patent expired, Lipitor was the best-selling drug of all time. Lipitor, the drug that artificially lowers cholesterol, outsold almost all other drugs combined during the height of its run, before the patent ran out allowing generics to enter the market. The FDA did not issue warnings about the dangerous side effects of cholesterol-lowering drugs until after Lipitor's patent expired. The information here comes from an attorney, as attorneys across the nation see the economic opportunities now to sue Pfizer for damage done to millions of peoples' health.